Updates

Vistry - Gain since last Novembers write-up: 127%

July 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Shares in Vistry have hit £13, a huge return on the 573p at which I featured them last November. Since then they have climbed remorselessly following a succession of positive updates, the latest of which has raised pretax profit guidance for FY’21 from at least £310m to c. £325m. Vistry said average private weekly sales rates rose a stellar 21% on 2019 to 0.75 per sales outlet per week (2020: 0.44; 2019: 0.62), while house building is on track to complete c. 6,500 units (FY’20: 4,652), ahead of previous expectations and with an improvement in gross margin to boot. Vistry Partnerships has continued its excellent progress towards FY’22 targets of £1billion sales and a 10% operating margin. The forward sales position stre ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Forterra

UDG Healthcare - 1023p-a-share cash offer

Vistry (December 2024)

Vistry - Shares hit new high above £14 (November 2024)

Vistry (July 2024)

Vistry - Shares double since main write-up (June 2024)

Vistry (December 2023)

Vistry - Increased focus on social / affordable housing and pre-sales could double profit to £800m medium term (November 2023)

Vistry (September 2023)

Vistry (August 2023)

Vistry - Countryside synergies upgraded by £10m (May 2023)

Vistry (March 2023)

Vistry - Transformative acquisition increases fast-growing social housing to over 50% sales (December 2022)

Vistry (April 2022)

Vistry (January 2022)

Vistry (November 2021)

Vistry (October 2021)

Vistry (April 2021)

Vistry (March 2021)

Vistry - Net debt falls from £357m to just £40m (January 2021)

Vistry (September 2020)

Vistry - Partnerships division transforms growth prospects (July 2020)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X